New York Oncology Hematology, P.C. is a clinical research site located in Clifton Park, New York, United States 12065.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Oncology Hematology, P.C. has participated in 7 clinical trials.
Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.
Sponsors: Pfizer, Calithera Biosciences, Inc, AVEO Pharmaceuticals, Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Oncology Hematology, P.C. has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Oncology Hematology, P.C. has 7 clinical trials on record. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.
Yes — New York Oncology Hematology, P.C. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.